scholarly article | Q13442814 |
P50 | author | Lauren Edgar | Q85904829 |
Giuseppe Orlando | Q88611383 | ||
Andrea Angeletti | Q39789088 | ||
Paolo Cravedi | Q63926440 | ||
P2093 | author name string | Laura Perin | |
Riccardo Tamburrini | |||
Samira Farouk | |||
Jerome Duisit | |||
P2860 | cites work | Interaction of the natural anti-Gal antibody with alpha-galactosyl epitopes: a major obstacle for xenotransplantation in humans | Q71604759 |
alpha-galactosyl epitopes on glycoproteins of porcine renal extracellular matrix | Q73395982 | ||
Xenogeneic extracellular matrix grafts elicit a TH2-restricted immune response | Q74131353 | ||
IL-10 is required for human CD4(+)CD25(+) regulatory T cell-mediated suppression of xenogeneic proliferation | Q83003366 | ||
Biomaterials and host versus graft response: a short review | Q26764759 | ||
T Cells: Soldiers and Spies--The Surveillance and Control of Effector T Cells by Regulatory T Cells | Q26823613 | ||
Immunogenicity in xenogeneic scaffold generation: antigen removal vs. decellularization | Q26851589 | ||
TGF-β: guardian of T cell function | Q27012877 | ||
Anti-Gal: an abundant human natural antibody of multiple pathogeneses and clinical benefits | Q27021788 | ||
Alternative activation of macrophages | Q27860939 | ||
Neutrophil extracellular traps kill bacteria | Q27860996 | ||
Current achievements and future perspectives in whole-organ bioengineering | Q28081535 | ||
Human natural anti-alpha-galactosyl IgG. II. The specific recognition of alpha (1----3)-linked galactose residues | Q28336207 | ||
Extracellular matrix from porcine small intestinal submucosa (SIS) as immune adjuvants | Q28743077 | ||
Monocyte and macrophage heterogeneity | Q29547438 | ||
The chemokine system in diverse forms of macrophage activation and polarization | Q29547719 | ||
The extracellular matrix: not just pretty fibrils | Q29617251 | ||
Macrophage activation and polarization: nomenclature and experimental guidelines | Q29620642 | ||
Bioengineering Human Myocardium on Native Extracellular Matrix. | Q30706278 | ||
Immunogenicity of decellularized porcine liver for bioengineered hepatic tissue | Q34037106 | ||
Physiology of wound healing | Q34080923 | ||
Neutrophil kinetics in health and disease. | Q34092240 | ||
Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys | Q34480315 | ||
Decellularized human liver as a natural 3D-scaffold for liver bioengineering and transplantation | Q34488546 | ||
Hydrogels and scaffolds for immunomodulation | Q34725541 | ||
Clinical transplantation of a tissue-engineered airway. | Q34885214 | ||
ECM components guide IL-10 producing regulatory T-cell (TR1) induction from effector memory T-cell precursors. | Q34978026 | ||
Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy. | Q35053924 | ||
Macrophage polarization in response to ECM coated polypropylene mesh | Q35141561 | ||
Wound healing: an overview of acute, fibrotic and delayed healing | Q35650806 | ||
Foreign body reaction to biomaterials | Q36575306 | ||
Natural origin biodegradable systems in tissue engineering and regenerative medicine: present status and some moving trends | Q36782519 | ||
Immune response to biologic scaffold materials | Q37033547 | ||
Immunomodulatory effect of a decellularized skeletal muscle scaffold in a discordant xenotransplantation model | Q37143618 | ||
Intact extracellular matrix and the maintenance of immune tolerance: high molecular weight hyaluronan promotes persistence of induced CD4+CD25+ regulatory T cells. | Q37326764 | ||
Removal of alpha-Gal epitopes from porcine aortic valve and pericardium using recombinant human alpha galactosidase A. | Q37417959 | ||
Materials engineering for immunomodulation | Q37639157 | ||
Macrophage polarization: an opportunity for improved outcomes in biomaterials and regenerative medicine | Q37990243 | ||
Multiple roles for neutrophils in atherosclerosis | Q37994653 | ||
Organ bioengineering and regeneration as the new Holy Grail for organ transplantation | Q38115663 | ||
Stem cells with decellularized liver scaffolds in liver regeneration and their potential clinical applications | Q38209488 | ||
Avoiding detrimental human immune response against Mammalian extracellular matrix implants | Q38260188 | ||
Nanoparticle-based immunotherapy for cancer | Q38282133 | ||
Neutrophil's weapons in atherosclerosis | Q38628708 | ||
In vivo delivery of peptides and Toll-like receptor ligands by mannose-functionalized polymeric nanoparticles induces prophylactic and therapeutic anti-tumor immune responses in a melanoma model | Q38931309 | ||
Immune Responses to Tissue-Restricted Nonmajor Histocompatibility Complex Antigens in Allograft Rejection | Q39121365 | ||
Dendritic cells in host response to biologic scaffolds | Q39141871 | ||
The host response to naturally-derived extracellular matrix biomaterials | Q39169131 | ||
Activation of Macrophages in Response to Biomaterials | Q39271657 | ||
Renal Extracellular Matrix Scaffolds From Discarded Kidneys Maintain Glomerular Morphometry and Vascular Resilience and Retains Critical Growth Factors | Q39277645 | ||
A step towards clinical application of acellular matrix: A clue from macrophage polarization. | Q39439987 | ||
Neutrophils, host defense, and inflammation: a double-edged sword | Q40652717 | ||
Mechanisms underlying heterologous skin scaffold-mediated tissue remodeling | Q41390140 | ||
Comparative Decellularization and Recellularization of Wild-Type and Alpha 1,3 Galactosyltransferase Knockout Pig Lungs: A Model for Ex Vivo Xenogeneic Lung Bioengineering and Transplantation | Q41529439 | ||
In Vivo Remodeling of Fibroblast-Derived Vascular Scaffolds Implanted for 6 Months in Rats | Q42356641 | ||
The Human Pancreas as a Source of Protolerogenic Extracellular Matrix Scaffold for a New-generation Bioartificial Endocrine Pancreas | Q42571176 | ||
Comparison of Gal and non-Gal-mediated cardiac xenograft rejection | Q42746065 | ||
Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells. | Q45972665 | ||
Decellularized human colorectal cancer matrices polarize macrophages towards an anti-inflammatory phenotype promoting cancer cell invasion via CCL18. | Q45978967 | ||
Recycling organs - growing tailor-made replacement kidneys | Q46189530 | ||
In vitro expanded human CD4+CD25+ regulatory T cells are potent suppressors of T-cell-mediated xenogeneic responses | Q46518653 | ||
Engineering pulmonary vasculature in decellularized rat and human lungs. | Q46670073 | ||
Biocompatibility and potential of acellular human amniotic membrane to support the attachment and proliferation of allogeneic cells | Q46679049 | ||
Solubilized extracellular matrix from brain and urinary bladder elicits distinct functional and phenotypic responses in macrophages | Q48331031 | ||
Decellularization of the Porcine Ear Generates a Biocompatible, Nonimmunogenic Extracellular Matrix Platform for Face Subunit Bioengineering. | Q50982856 | ||
A porcine-derived acellular dermal scaffold that supports soft tissue regeneration: removal of terminal galactose-alpha-(1,3)-galactose and retention of matrix structure. | Q51838397 | ||
Biocompatibility and Immunophenotypic Characterization of a Porcine Cholecyst-derived Scaffold Implanted in Rats. | Q53412911 | ||
Percutaneous autologous bone-marrow grafting for nonunions. Surgical technique. | Q53521804 | ||
Production and Implantation of Renal Extracellular Matrix Scaffolds From Porcine Kidneys as a Platform for Renal Bioengineering Investigations | Q57395896 | ||
Collagen fragments modulate innate immunity | Q62490794 | ||
P433 | issue | 12 | |
P921 | main subject | immunology | Q101929 |
P304 | page(s) | 1199-1208 | |
P577 | publication date | 2017-10-05 | |
P1433 | published in | Transplant International | Q15762140 |
P1476 | title | Regenerative immunology: the immunological reaction to biomaterials | |
P478 | volume | 30 |